INTERNATIONAL PATENT: EISBACH BIO GMBH FILES APPLICATION FOR "CRYSTALLINE FORMS OF AN ALC1 INHIBITOR USEFUL IN THE TREATMENT OF CANCER"

GENEVA, Dec. 1 -- EISBACH BIO GMBH (Am Klopferspitz 1982152 Martinsried) filed a patent application (PCT/EP2025/063922) for "CRYSTALLINE FORMS OF AN ALC1 INHIBITOR USEFUL IN THE TREATMENT OF CANCER" on May 21, 2025. With publication no. WO/2025/242703, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MENZER, William M. (Max-Lebesch-Platz 3481377 Munchen)

Abstract: The present invention relates to novel crystal forms of sodium 7-(4-bromophenyl)-2-oxo-9- (trifluoromethyl)-1,2-dihydropyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4...